Leibniz Institute for Prevention Research and Epidemiology-BIPS, Achterstr. 30, 28359, Bremen, Germany.
Faculty of Human and Health Sciences, University of Bremen, Bremen, Germany.
Mol Med. 2023 Mar 30;29(1):41. doi: 10.1186/s10020-023-00629-2.
Differential expression analysis is usually adjusted for variation. However, most studies that examined the expression variability (EV) have used computations affected by low expression levels and did not examine healthy tissue. This study aims to calculate and characterize an unbiased EV in primary fibroblasts of childhood cancer survivors and cancer-free controls (N0) in response to ionizing radiation.
Human skin fibroblasts of 52 donors with a first primary neoplasm in childhood (N1), 52 donors with at least one second primary neoplasm (N2 +), as well as 52 N0 were obtained from the KiKme case-control study and exposed to a high (2 Gray) and a low dose (0.05 Gray) of X-rays and sham- irradiation (0 Gray). Genes were then classified as hypo-, non-, or hyper-variable per donor group and radiation treatment, and then examined for over-represented functional signatures.
We found 22 genes with considerable EV differences between donor groups, of which 11 genes were associated with response to ionizing radiation, stress, and DNA repair. The largest number of genes exclusive to one donor group and variability classification combination were all detected in N0: hypo-variable genes after 0 Gray (n = 49), 0.05 Gray (n = 41), and 2 Gray (n = 38), as well as hyper-variable genes after any dose (n = 43). While after 2 Gray positive regulation of cell cycle was hypo-variable in N0, (regulation of) fibroblast proliferation was over-represented in hyper-variable genes of N1 and N2+. In N2+, 30 genes were uniquely classified as hyper-variable after the low dose and were associated with the ERK1/ERK2 cascade. For N1, no exclusive gene sets with functions related to the radiation response were detected in our data.
N2+ showed high degrees of variability in pathways for the cell fate decision after genotoxic insults that may lead to the transfer and multiplication of DNA-damage via proliferation, where apoptosis and removal of the damaged genome would have been appropriate. Such a deficiency could potentially lead to a higher vulnerability towards side effects of exposure to high doses of ionizing radiation, but following low-dose applications employed in diagnostics, as well.
差异表达分析通常需要进行变异调整。然而,大多数研究检测表达变异性(EV)时都使用了受低表达水平影响的计算方法,并且没有检测健康组织。本研究旨在计算和描述儿童癌症幸存者和无癌对照者(N0)的原代成纤维细胞在电离辐射下的无偏 EV。
从 KiKme 病例对照研究中获得了 52 名患有儿童期原发性肿瘤的供体(N1)、52 名至少有一个第二原发性肿瘤的供体(N2+)和 52 名 N0 的人皮肤成纤维细胞,并分别用高(2 Gray)和低剂量(0.05 Gray)X 射线和假照射(0 Gray)进行照射。然后,根据供体组和辐射处理,将基因分类为低、非或高变量基因,并检查是否存在过表达的功能特征。
我们发现 22 个基因在供体组之间存在显著的 EV 差异,其中 11 个基因与电离辐射、应激和 DNA 修复反应相关。在 N0 中,唯一一组和可变性分类组合的基因数量最多:0 Gray(n=49)、0.05 Gray(n=41)和 2 Gray(n=38)后低表达的基因,以及任何剂量后高表达的基因(n=43)。虽然在 N0 中,2 Gray 后细胞周期的正调控呈低变异性,但 N1 和 N2+中的高变异性基因中过表达了(调节)成纤维细胞增殖。在 N2+中,30 个基因在低剂量后被唯一分类为高变异性,与 ERK1/ERK2 级联反应相关。对于 N1,我们的数据中没有检测到与辐射反应相关的功能的特有基因集。
N2+在受到遗传毒性损伤后,细胞命运决策的途径表现出高度的可变性,这可能导致通过增殖转移和倍增 DNA 损伤,而凋亡和去除受损基因组本应是合适的。这种缺陷可能会使儿童癌症幸存者和无癌对照者(N2+)在接触高剂量电离辐射时更容易受到副作用的影响,但在接受诊断应用的低剂量时也会受到影响。